AFP and hepatocellular carcinoma: Serum biomarkers are used to help identify patients early, such as alpha-fetoprotein for hepatocellular carcinoma or CA19.9 for pancreatic cancer; however, these are not sensitive or specific enough to be a reliable diagnostic test [26,58].